Hong Kong Asia Medical Group is a cardiovascular specialty medical group founded in 1999 that operates hospitals and services across mainland China, Hong Kong and Japan. The group traces its origins to Wuhan Asia Heart Hospital and has treated about 5 million patients over 22 years. It emphasizes clinical care alongside research and education and has built an internationalized management and talent-development system. The group cites strengths in clinical service capabilities, hospital management replication, clinical innovation translation, and joint talent training. Financially, the company recently completed a $400 million Series D financing. Management says proceeds will support service innovation, continued expansion, and the goal of becoming an international first-class integrated cardiac medicine group combining treatment, patient care, research and education.

Total raised

$400M

Funding rounds

1

Latest round

Series D

Latest activity

Feb 2022